s From Eli Lilly Canada Inc
Selected Abstract
American Pharmaceutical Partners Acquires Canadian Market Rights to Five Injectable Products From Eli Lilly Canada Inc.
American Pharmaceutical Partners, Inc. , today announced that it has acquired from Eli Lilly Canada Inc. (a wholly-owned subsidiary of Eli Lilly and Company NYSE: LLY) Canadian market and trademark rights for four proprietary products, Tazidime(R) (ceftazidime), Kefurox(R) (cefuroxime), Kefzol(R) ... July 16, 2003; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles No Results Found.
|
